clinical pipeline

Kailera Raises $600 Million to Launch Global Phase III Program for Obesity Drug

2 weeks ago talkbio0Tagged Bain Capital, clinical pipeline, Funding, GLP-1/GIP Dual Agonist, Kailera, Obesity Drug, Phase 3 Clinical Trials, Series B financing, weight loss therapy

Kailera; obesity drug; Phase III clinical trial; KAI-9531; GLP-1/GIP dual agonist; Series B financing; Bain Capital; weight loss therapy; clinical pipeline; biotech funding

Odyssey Therapeutics Secures $213M Series D to Accelerate Autoimmune Clinical Portfolio

2 months ago talkbio0Tagged Autoimmune Diseases, clinical pipeline, Immunoregulation, Inhibitor, investors, Odyssey, Precision - temporal, preclinical programs, Protac, RIPK2, Series D financing, Technology

Odyssey Therapeutics; Series D financing; $213 million; autoimmune diseases; clinical pipeline; preclinical programs; precision immunomodulation; RIPK2 inhibitor; PROTAC technology; investors

Novartis CEO Reveals Strategic Pipeline Reduction by 40% Based on Data-Driven Insights

11 months ago talkbio0Tagged clinical pipeline, Data-Driven, Decision, Drug Industry, Novartis, strategic reduction

Novartis, clinical pipeline, data-driven decisions, pharmaceutical industry, strategic reduction